09:56 AM EST - Microbix Biosystems Inc : reported that they have signed a Letter of Intent to market the Thrombolytic drug, Urokinase in the North American markets. The estimated market size for Urokinase use in the U.S. alone is expected to touch $400 million by 2020. Microbix Biosystems Inc
shares T.MBX are trading up $0.02 at $0.19.
